Jacobson Pharma Corporation Limited (2633.HK)
HKD 1.25
(-1.57%)
HKD 1.25
(-1.57%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.09 Billion HKD | -48.66% |
| 2022 | 2.12 Billion HKD | 18.16% |
| 2021 | 1.79 Billion HKD | -10.44% |
| 2020 | 2 Billion HKD | 1.67% |
| 2019 | 1.97 Billion HKD | 25.46% |
| 2018 | 1.57 Billion HKD | -1.85% |
| 2017 | 1.6 Billion HKD | 33.85% |
| 2016 | 1.19 Billion HKD | 38.32% |
| 2015 | 865.9 Million HKD | 23.95% |
| 2014 | 698.57 Million HKD | 29.41% |
| 2013 | 539.82 Million HKD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | 1.68 Billion HKD | 0.0% |
| 2023 FY | 1.09 Billion HKD | -48.66% |
| 2023 Q4 | 1.09 Billion HKD | 0.0% |
| 2022 Q4 | 2.12 Billion HKD | 0.0% |
| 2022 FY | 2.12 Billion HKD | 18.16% |
| 2022 Q2 | 2.05 Billion HKD | 0.0% |
| 2021 FY | 1.79 Billion HKD | -10.44% |
| 2021 Q4 | 1.79 Billion HKD | 0.0% |
| 2021 Q2 | 1.93 Billion HKD | 0.0% |
| 2020 Q4 | 2 Billion HKD | 0.0% |
| 2020 FY | 2 Billion HKD | 1.67% |
| 2020 Q2 | 2.03 Billion HKD | 0.0% |
| 2019 Q4 | 1.97 Billion HKD | 0.0% |
| 2019 FY | 1.97 Billion HKD | 25.46% |
| 2019 Q2 | 1.92 Billion HKD | 0.0% |
| 2018 Q4 | 1.57 Billion HKD | 0.0% |
| 2018 Q2 | 1.55 Billion HKD | 0.0% |
| 2018 FY | 1.57 Billion HKD | -1.85% |
| 2017 Q2 | 1.22 Billion HKD | 0.0% |
| 2017 FY | 1.6 Billion HKD | 33.85% |
| 2017 Q4 | 1.6 Billion HKD | 0.0% |
| 2016 Q2 | 845.52 Million HKD | 0.0% |
| 2016 FY | 1.19 Billion HKD | 38.32% |
| 2016 Q4 | 1.19 Billion HKD | 0.0% |
| 2015 FY | 865.9 Million HKD | 23.95% |
| 2015 Q4 | 865.9 Million HKD | 0.0% |
| 2014 FY | 698.57 Million HKD | 29.41% |
| 2014 Q4 | 650.23 Million HKD | 0.0% |
| 2013 FY | 539.82 Million HKD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 142.28 Million HKD | -666.431% |
| Grand Pharmaceutical Group Limited | 7.24 Billion HKD | 84.948% |
| Extrawell Pharmaceutical Holdings Limited | 170.4 Million HKD | -539.935% |
| Wai Yuen Tong Medicine Holdings Limited | 709.65 Million HKD | -53.666% |
| Qianhai Health Holdings Limited | 94 Million HKD | -1060.063% |
| Lee's Pharmaceutical Holdings Limited | 930.06 Million HKD | -17.249% |
| Essex Bio-Technology Limited | 903.78 Million HKD | -20.659% |
| Tongfang Kontafarma Holdings Limited | 665.38 Million HKD | -63.888% |
| PuraPharm Corporation Limited | 689.65 Million HKD | -58.123% |
| SSY Group Limited | 4.49 Billion HKD | 75.734% |
| JBM (Healthcare) Limited | 366.75 Million HKD | -197.337% |
| China Resources Pharmaceutical Group Limited | 168.46 Billion HKD | 99.353% |